Rossari Biotech Ltd (ROSSARI) Financial Statements

2 Followers

Rossari Biotech Ltd Financial Overview

Rossari Biotech Ltd's market cap is currently ₹26.59B. The company's EPS TTM is ₹24.68; its P/E ratio is 11.40; and it has a dividend yield of 0.09%. Rossari Biotech Ltd is scheduled to report earnings on April 27, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 23.96B	₹ 20.80B	₹ 18.31B	₹ 16.56B	₹ 14.83B
Gross Profit	₹ 4.94B	₹ 6.47B	₹ 5.26B	₹ 2.80B	₹ 2.29B
Operating Income	₹ 2.07B	₹ 5.15B	₹ 1.87B	₹ 1.55B	₹ 1.32B
EBITDA	₹ 2.86B	₹ 2.65B	₹ 2.57B	₹ 2.12B	₹ 1.94B
Net Income	₹ 1.49B	₹ 1.36B	₹ 1.31B	₹ 1.07B	₹ 976.74M
Balance Sheet
Cash & Short-Term Investments	₹ 1.27B	₹ 1.14B	₹ 667.85M	₹ 1.52B	₹ 644.26M
Total Assets	₹ 22.89B	₹ 18.96B	₹ 15.72B	₹ 13.68B	₹ 12.57B
Total Debt	₹ 4.36B	₹ 2.18B	₹ 1.19B	₹ 739.28M	₹ 84.27M
Net Debt	₹ 3.44B	₹ 1.61B	₹ 936.22M	₹ 40.96M	₹ -290.50M
Total Liabilities	₹ 9.55B	₹ 7.11B	₹ 5.24B	₹ 4.52B	₹ 4.52B
Stockholders' Equity	₹ 13.33B	₹ 11.85B	₹ 10.48B	₹ 9.15B	₹ 8.05B
Cash Flow
Free Cash Flow	₹ -2.20B	₹ -210.69M	₹ -880.28M	₹ 1.20B	₹ -88.67M
Operating Cash Flow	₹ 451.63M	₹ 1.37B	₹ 432.55M	₹ 1.52B	₹ 293.58M
Investing Cash Flow	₹ -2.22B	₹ -1.84B	₹ -1.03B	₹ -1.81B	₹ -2.99B
Financing Cash Flow	₹ 2.09B	₹ 649.01M	₹ 161.85M	₹ 608.55M	₹ 2.92B

Currency in INR

Rossari Biotech Ltd Earnings and Revenue History

Income Statement >

Rossari Biotech Ltd Debt to Assets

Balance Sheet >

Rossari Biotech Ltd Cash Flow

Cash Flow >

Rossari Biotech Ltd Forecast EPS vs Actual EPS

Earnings >